About Biovalence Technologies
Biovalence Technologies is a company based in Singapore (Singapore) founded in 2011 by Alfred Chua. It operates as a B2B. Biovalence Technologies operates in a competitive market with competitors including Adaptive Biotechnologies, Moderna, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Singapore, Singapore
- Founders Alfred Chua
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Biovalence Technologies Llp
- Date of Incorporation 26 Jun, 2015
- Jurisdiction Patna, Bihar, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biovalence Technologies
Detailed funding history for Biovalence Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biovalence Technologies
Investment portfolio details for Biovalence Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biovalence Technologies
Detailed financials for Biovalence Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biovalence Technologies Comparisons
Peer comparison for Biovalence Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biovalence Technologies
Biovalence Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adaptive Biotechnologies, Moderna, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Developer of biologics to treat hepatitis B infection
|
|
| Locked | Locked | Locked |
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
Detailed competitors of Biovalence Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biovalence Technologies
Complete news archive for Biovalence Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biovalence Technologies
Biovalence Technologies was founded in 2011.
Biovalence Technologies is headquartered in Singapore, Singapore.
Alfred Chua is the current CEO of Biovalence Technologies. They have also founded this company.
Biovalence Technologies, established in 2011, excels in providing healthcare solutions, advancing biotech innovations, therapeutics development, and antiviral solutions. Delivers advanced genomics and proteomics solutions to develop innovative antiviral therapies for infectious diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Biovalence Technologies's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.